Manoalide: Difference between revisions
CSV import |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 29: | Line 29: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Manoalide.svg|Manoalide | |||
</gallery> | |||
Latest revision as of 00:40, 17 March 2025
Manoalide is a natural compound that is derived from the marine sponge Luffariella variabilis. It is known for its anti-inflammatory properties and has been studied for its potential use in the treatment of various diseases.
History[edit]
Manoalide was first isolated in 1983 from the marine sponge Luffariella variabilis. The compound was named after Manoa, the Hawaiian word for "vast", in reference to the vast potential of the marine environment as a source of new drugs.
Structure and Properties[edit]
Manoalide is a sesterterpenoid, a class of terpenes that contain 25 carbon atoms. It has a complex structure that includes a lactone ring and several hydroxyl groups. The compound is highly lipophilic, which allows it to easily cross cell membranes.
Biological Activity[edit]
Manoalide has a variety of biological activities. It is best known for its anti-inflammatory effects, which are believed to be due to its ability to inhibit the enzyme phospholipase A2. This enzyme is involved in the production of inflammatory mediators, so inhibiting it can reduce inflammation.
In addition to its anti-inflammatory effects, manoalide has also been found to have analgesic, antifungal, and antiviral activities. It has been studied for its potential use in the treatment of diseases such as arthritis, cancer, and viral infections.
Research and Clinical Trials[edit]
While manoalide has shown promise in laboratory studies, it has not yet been approved for use in humans. Clinical trials are needed to determine the safety and efficacy of this compound in patients.
See Also[edit]
References[edit]
<references />


